Ann: Preliminary Final Report, page-3

Not arf, stellar reading.

From prior announcement...
"The Company had arranged to raise capital to fund operating expenses and progress the KT009 project under its Licence. However, the Covid 19 pandemic effect on capital markets caused that arrangement to be abandoned at a critical time."

From the latest announcement...
" $528,011 gain on disposal of intellectual property" I may be wrong, but I am assuming that is the intellectual property for their syringe technology.
So it looks like they have nothing happening at all.

Waiting with baited breath NOT for the next chapter(if there is one).